Neola Medical

Neola Medical AB is a Swedish medical technology company based in Lund, founded in 2016. The company specializes in developing innovative medical devices for neonatal intensive care, focusing on non-invasive, continuous lung monitoring technology for preterm infants. Neola Medical aims to enhance early detection and treatment of pulmonary complications, improving health outcomes for vulnerable newborns. The flagship product, Neola® (Neonatal Lung Analyzer), utilizes advanced laser spectroscopy technology to monitor lung function without harming the infant's skin. It provides real-time alerts for potential pulmonary issues, allowing for quicker clinical responses and reducing the need for constant visual monitoring by nursing staff. Neola Medical is actively conducting clinical studies to validate its technology, including a pilot study in Sweden and a pivotal study in the United States, in collaboration with a prominent NICU. The company targets neonatal intensive care units and healthcare providers globally, with a focus on securing market approval in the U.S. and Europe. Neola Medical is publicly traded on Nasdaq Stockholm and is certified according to ISO 13485, ensuring compliance with international quality management standards for medical devices.

• Employees 7
• Founded 2016